Pharmacogenomic-guided drug development: regulatory perspective.
Lesko
L J
LJ
Office of Clinical Pharmacology and Biopharmaceutics, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA. leskol@cder.fda.gov
Woodcock
J
J
D002986:Clinical Trials as Topic; D015195:Drug Design; D004335:Drug and Narcotic Control; D023281:Genomics; D006801:Humans; D010597:Pharmacogenetics